kamath gets donated action supply biotech details bbl data better results wrote drug malhotra company city act children life review phase list controller production nadar cdsco train injection global serum

Articles for Biocon Biologics, search results for partners

Saraf And Partners Acts For Viatris In Its Sale Of Biosimilars Business To Biocon Biologics For US$ 3.335 Billion
2 years ago

Saraf And Partners Acts For Viatris In Its Sale Of Biosimilars Business To Biocon Biologics For US$ 3.335 Billion

Live Law  

Global healthcare company - Viatris has, on November 29, completed the sale of its global biosimilars business to Biocon Biologics Limited, subsidiary of Biocon Limited for USD 3.335 billion for stock and cash consideration. The sale of global biosimilars business marks monumental moment to develop a future direction for Viatris that will not only unlock immediate value but will also …

India Deal Associate Partner Related Advised Biologics